Ardent Health (ARDT) closed at $18.10 on November 16, 2026, up 1.7% from the previous close, on volume of 711,328 shares (30-day average 694,699).
Data as of November 16, 2026.
Managed care drops as U.S. seeks crackdown on Medicare, Medicaid fraud
Seeking Alpha News (Tue, 17-Nov 8:32 AM ET)
TipRanks (Mon, 16-Nov 6:16 AM ET)
Ardent Health Raises EBITDA Outlook on Strong Quarter
TipRanks (Sat, 14-Nov 7:41 PM ET)
Ardent Health to buy Boone Health for purchase price of $47M in cash
Seeking Alpha News (Thu, 12-Nov 4:33 PM ET)
Ardent Health Announces Definitive Agreement to Acquire Boone Health
Business Wire (Thu, 12-Nov 4:15 PM ET)
Ardent Health to Participate in the UBS Global Healthcare Conference
Business Wire (Mon, 9-Nov 8:00 AM ET)
Market Chameleon (Thu, 5-Nov 6:50 AM ET)
Ardent Health Reports Third Quarter 2026 Results
Business Wire (Wed, 4-Nov 4:15 PM ET)
Ardent Health Appoints Gaurav Khanna as Chief Digital & Information Officer
Business Wire (Wed, 21-Oct 4:15 PM ET)
Ardent Health Announces Third Quarter 2026 Results Conference Call and Webcast Date
Business Wire (Thu, 15-Oct 4:15 PM ET)
Ardent Health Inc is a provider of healthcare in growing mid-sized urban communities across the U.S and operating in eight growing mid-sized urban markets across six states Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. The main focus on people and investments in services and technologies.
Ardent Health trades on the NYSE stock market under the symbol ARDT.
As of November 17, 2026, ARDT stock price declined to $18.09 with 22,942 million shares trading.
ARDT has a beta of -0.10, meaning it tends to be less sensitive to market movements. ARDT has a correlation of 0.00 to the broad based SPY ETF.
ARDT has a market cap of $2.55 billion. This is considered a Mid Cap stock.
Last quarter Ardent Health reported $2 billion in Revenue and $.31 earnings per share. This beat revenue expectation by $18 million and exceeded earnings estimates by $.07.
The top ETF exchange traded funds that ARDT belongs to (by Net Assets): AVUV, IWM, BSVO, VTI, FYX.
ARDT has outperformed the market in the last year with a price return of +100.8% while the SPY ETF gained +11.1%. ARDT has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +65.8% and +54.2%, respectively, while the SPY returned -4.6% and -1.8%, respectively.
ARDT support price is $17.56 and resistance is $18.65 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ARDT shares will trade within this expected range on the day.